HighVista Strategies »

Avantor shares owned by HighVista Strategies

Quarter-by-quarter ownership of Avantor (AVTR) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Avantor

Tip: Access up to 7 years of quarterly data

All positions including Avantor held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avantor by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.2M 172k 12.48

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Avantor

Dodge & Cox
Vanguard Group
BlackRock
Barrow, Hanley, Mewhinney & Strauss
T. Rowe Price Investment Management
State Street Corporation
Engine Capital Management
Greenhaven Associates
Invesco
Clarkston Capital Partners
New Mountain Capital
Dimensional Fund Advisors
London Company
Geode Capital Management
Manufacturers Life Insurance Company

View all funds holding Avantor